Takeda Pharmaceutical
TAK
#469
Rank
NZ$86.11 B
Marketcap
NZ$25.88
Share price
0.47%
Change (1 day)
14.25%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): NZ$3.36 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are NZ$29.52 Billion. In 2024 the company made an earning of NZ$3.87 Billion a decrease over its 2023 earnings that were of NZ$3.97 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$3.36 B-13.07%
2024 NZ$3.87 B-2.41%
2023 NZ$3.97 B-28.14%
2022 NZ$5.52 B-40.9%
2021 NZ$9.35 B78.24%
2020 NZ$5.24 B246.1%
2019 NZ$1.51 B-48.79%
2018 NZ$2.95 B-23.64%
2017 NZ$3.87 B21.7%
2016 NZ$3.18 B-253.01%
2015 -NZ$2.09 Billion-159.65%
2014 NZ$3.48 B13%
2013 NZ$3.08 B2.46%
2012 NZ$3.01 B-57.05%
2011 NZ$7.01 B-10.49%
2010 NZ$7.83 B-3.99%
2009 NZ$8.16 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$56.26 B 1,481.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.80 B 344.15%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
NZ$20.58 B 478.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.51 B 701.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
-NZ$1.38 Billion-138.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$1.59 B-55.15%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
NZ$14.31 B 302.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$16.19 B 355.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$40.10 B 1,026.95%๐Ÿ‡บ๐Ÿ‡ธ USA